EMBRYONIC STEM CELLS,STEMCELLS,DEPARTMENT OF HEALTH HUMAN,SEARCH,TIPS,INFO,RESEARCH,TOPICS,FEDERAL,POLICY,GLOSSARY,STEM CELL,INFORMATION,GENERAL,CLINICAL TRIALS,FUNDING,CURRENT,RESEARCH POLICY,SITE MAP,JUMP,NAVIGATION,YOU ARE,JUNYING YU,JAMES A THOMSON,HUMAN,EMBRYONIC STEM,ES CELLS,CAPTURE,IMAGINATION,IMMORTAL,ALMOST,UNLIMITED,DEVELOPMENTAL,POTENTIAL,DERIVED,MONTHS,CULTURE,DISHES,REMARKABLE,CELLS,ABILITY,RANGING,MUSCLE,NERVE,BLOOD,POTENTIALLY,CELL TYPE,THE BODY,PROLIFERATIVE,PROMISES,SUPPLY,CELL,BASIC RESEARCH,TRANSPLANTATION,THERAPIES,DISEASES,HEART DISEASE,PARKINSONS DISEASE,LEUKEMIA,HERE,DISCUSS,ORIGIN,PROPERTIES,MEDICINE,RECENT,PROGRESS,PRESIDENT GEORGE W BUSH,FEDERAL FUNDING,THE FIRST TIME,PREVIOUS,REPORT,DISCUSSED,PRIOR,JUNE 17,FIGURE 1,HUMAN EMBRYONIC STEM CELLS,WINSLOW,EMBRYOS,STAGE,IMPLANTATION,NORMALLY,UTERUS,FERTILIZATION,OVIDUCT,THE NEXT,DAYS,CLEAVAGE,DIVISIONS,EMBRYO,TRAVELS,DOWN,THE CELLS,BLASTOMERES,CLEAVAGE STAGE,DO NOT,LOOK,SPECIALIZED CELLS,ADULT,COMMITTED,BECOMING,PARTICULAR,TYPE,DIFFERENTIATED CELL,INDEED,THE POTENTIAL,GIVE,RISE,DIFFERENTIATION,EVENT,HUMANS,DEVELOPMENT,OUTER,LAYER,PLACENTA,TROPHECTODERM,SEPARATES,INNER CELL MASS,QUICKLY,DIFFERENTIATE,LIMITED,NORMAL,EMBRYONIC,ENVIRONMENT,CULTURED,CONDITIONS,CONTINUE,REPLICATE,THEMSELVES,PLURIPOTENT,DERIVATION,MOUSE,REPORTED,ES CELL,LINES,RESULTS,IN VITRO FERTILIZATION,PROCESS,SPERM,CULTURE DISH,CLINICS,METHOD,CERTAIN,INFERTILITY,SOMETIMES,THE COURSE,LONGER,COUPLES,CHILDREN,NEARLY,FROZEN,STORAGE,THE UNITED STATES,ALONE,WHICH WILL,BE USED TO,DESTINED TO BE,SOURCES,PRESIDENT,BUSHS,DECISION,ELIGIBLE,ATTEMPTS,DERIVE,1980S,CULTURE MEDIA,HUMAN EMBRYOS,THUS,SINGLE CELL,FERTILIZED,ENOUGH,HEALTHY,BLASTOCYSTS,SPECIES,DIFFERENCES,MICE,EXPERIENCE,1990S,NON HUMAN PRIMATES,RHESUS MONKEY,THE COMMON,MARMOSET,CLOSER,NON HUMAN PRIMATE,IMPROVEMENTS,CULTURE MEDIUM,WITHOUT LIMIT,UNPRECEDENTED,ACCESS,THE HUMAN BODY,SUPPORT,FUNCTION,MATERIAL,TESTING,IMPROVE,SAFETY,EFFICACY,DRUGS,PROMISE,EXAMPLE,GENERALLY,TESTED,HUMAN HEART,CELL LINES,EXIST,RESEARCHERS,RELY,ANIMAL MODELS,ANIMAL,HEARTS,TOXIC,THE HUMAN HEART,IN DEATH,HEART,DRUG DISCOVERY,LEADING,SAFER,EFFECTIVE,TO HEART,THE PROMISE,STEM CELL RESEARCH,AMOUNT,TISSUE,WIDE,RANGE,DEGENERATIVE DISEASES,HUMAN DISEASES,CAUSED,DEATH,DYSFUNCTION,INSULIN,DIABETES,THE REPLACEMENT,NUMBER,CHALLENGES,DEVELOP,MANY YEARS,PATIENTS,IMPACT,HUMAN HEALTH,TRANSPLANTATION MEDICINE,BEGIN,LONG TERM,COUPLED WITH,INSIGHTS,NATURE,PLURIPOTENCY,GENETIC MANIPULATION,THE POSSIBILITIES,UNIQUE,FIBROBLASTS,FEEDER,PRESENCE,BOVINE,SERUM,FACTORS,SUSTAIN,APPEAR,DISTINCT,ADDITION,CYTOKINE,LEUKEMIA INHIBITORY FACTOR,MEDIUM,THE ABSENCE,ACTIVATION,STAT3,SIGNAL TRANSDUCERS,TRANSCRIPTION,PROTEIN,FREE CULTURE,PREVENT,NEURAL,RECENTLY,YING,THE COMBINATION,BONE MORPHOGENETIC PROTEINS,BMPS,SUFFICIENT,SELF,RENEWAL,INVOLVE,INDUCTION,INHIBITOR,PROTEINS,INHIBITION,EXTRACELLULAR,RECEPTOR,KINASE,P38 MITOGEN ACTIVATED PROTEIN,KINASES,MAPK,PROMOTE,PATHWAY,APPEARS,LEADS,THE RAPID,DIFFERENTIATION OF,ATTEMPTED,DEFINE,GROWTH FACTORS,REDUCE,EXPOSURE,NON HUMAN ANIMAL,GROWTH FACTOR,BFGF,CLONAL,CULTURE SYSTEM,DEVELOPED,MATRIX,MATRIGEL,LAMININ,PREVIOUSLY,CO CULTURE,DIRECT CONTACT,REMOVE,PATHOGENS,THE CULTURE,THE POSSIBILITY,TRANSFER,SYSTEMS,STILL REMAINS,WORK,DECREASE,VARIABILITY,THE CURRENT,SATO,WNT PATHWAY,OXIME,REPLACEMENT PRODUCT,AMIT,QUESTIONS,REASON TO BELIEVE,DEFINED,CONTAMINATION,SOON,ONCE,THE MEDIUM,THE CLONING,EFFICIENCY,COLONY,LESS THAN,ACCUMULATION,GENETIC,EPIGENETIC,CHANGES,PERIODS,KARYOTYPIC,RATE,DOMINATE,DEPEND,STATUS,EPIGENETICALLY,GENES,STABILITY,IMPRINTING,IMPRINTED GENES,CHANGE,PRESENT,PROBLEMS,ARE TO,CELL REPLACEMENT THERAPY,OPTIMIZING,ENDEAVOR,IDEAL,COST EFFECTIVE,EASY,TOOL,COMPONENTS,C,CELL GROWTH,DENSITIES,CHALLENGE,INCREMENTAL IMPROVEMENTS,PERIOD,TWELVE,ATTENTION,SOUTH KOREAN,GROUP,THE TECHNIQUE,SOMATIC CELL NUCLEAR TRANSFER,SOMATIC,NUCLEAR TRANSFER,STRIPPED,GENETIC MATERIAL,RESULTANT,IN VITRO,BLASTOCYST,NUCLEAR,INTENT,THE PROCEDURE,REJECTED,IMMUNE SYSTEM,TRANSPLANTATION THERAPY,ELEVEN,LINE IN,ABNORMALITIES,CLONED,ANIMALS,COSTS,INVOLVED,CLEAR,USEFUL,PROCEDURE,BE IN,APPLICATIONS,FOR SOME,AUTOIMMUNE DISEASES,TYPE I DIABETES,GENETICALLY,MATCHED,IMMUNE REJECTION,GENETIC DISORDERS,DETECTED,THE PRACTICE,PREIMPLANTATION GENETIC,DIAGNOSIS,EXCELLENT,MODEL,GENETIC MUTATIONS,CELL PROLIFERATION,EDITORS NOTE,PAPERS,PUBLISHED,WRITING,LUDWIG,PNAS,CHAPTER,WRITTEN,ADDRESS,NATURE GENETICS,GUNN,REFERENCED,RETRACTED,SCIENCE,DATE,WORLDWIDE,THE NATIONAL INSTITUTES OF,HEALTH,AS OF,AVAILABLE,EXPOSED,EIGHT,INITIAL,OPEN QUESTION,EXTENT,INDEPENDENT,FROM ONE,CANNOT,REASONABLE,SAMPLING,GENETIC DIVERSITY,ETHNIC GROUPS IN THE UNITED,CONSEQUENCES,DRUG TESTING,ADVERSE,COMPLEX,COMPONENT,NEED TO,ESTIMATES,ONLINE,VERSION,JUNE 15,STATE,HUMAN EMBRYONIC STEM CELL,OVERVIEW,USAGE,EXPERIMENTAL,FASCINATED,SCIENTISTS,LITTLE,RESTRICTED,FACTOR,OCT4,MARKER,INTACT,EXPRESSION,MUST,CRITICAL LEVEL,ITSELF,IDENTIFIED,NANOG,ESSENTIAL,MAINTENANCE,THE EXPRESSION,LEVEL,PROMOTER,FREE,GENE EXPRESSION PATTERNS,ADULT